Skip to main content
. 2018 Feb 7;15(4):4711–4719. doi: 10.3892/ol.2018.7982

Table I.

Factors and signal pathways involved in IL-37 expression.

Cell type Triggering factor Regulation Signal pathway involved (Refs.)
Monocytes TLR agonists Increased Unclear (28)
RAW cell line LPS Increased Unclear (17)
THP cells Triptolide, triptonide Increased ERK1/2, p38 (30)
Human cells TNF-a Increased MAPK, PI3K, NF-kB, AP-1 (28)
Epithelial cells Mannose-capped lipoarabinomannan Increased ERK1/2, p38 (40)
Keratinocytes Human β-defensin-3 Increased CCR6 (43)
Human cells IL-18, IFN-γ, IL-1b, TGF-β1 Increased Unclear (17,30,31)
Human cells GM-CSF, IL-4 Iecreased Unclear (17)
Endothelial cells ICAM-1, NF-κB Iecreased TLR2 activation (45)
BMDMs M-CSF, GM-CSF, IL-6 Iecreased Unclear (49)
HUVECs VEGF Iecreased Unclear (75)

BMDM, bone marrow-derived macrophages; HUVECs, human umbilical vein epithelial cells; IL, interleukin; TLR, toll-like receptors; LPS, lipopolysaccharide; TNF-a, tumor necrosis factor α; IFN, interferon; TGF-β1, transforming growth factor β1; GM-CSF, granulocyte macrophage-colony stimulating factor; NF-κB, nuclear factor κB; ICAM-1, intercellular adhesion molecule 1; M-CSF, macrophage colony stimulating factor; VEGF, vascular endothelial growth factor; ERK1/2, extracellular signal-related kinase; MAPK, mitogen activated protein kinase; PI3K, phosphoinositide 3-kinase; AP-1; activator protein 1; p38, tumor protein 38.